Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy's molecular target improved response. Read more …Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation
Major trial looks at most effective speech therapy for people with Parkinson's disease A major clinical trial has shown the Lee Silverman Voice Treatment (LSVT LOUD ) is more effective than the current speech and language therapy commonly provided, when treating patients with Parkinson's disease (PD). Read more …Major trial looks at most effective speech therapy for people with Parkinson's disease
Cirrhosis affects twice as many transgender adults as cisgender adults, study finds A new study has found a startling disparity in the frequency of liver disease for transgender individuals and highlights the need for more specialized care. Read more …Cirrhosis affects twice as many transgender adults as cisgender adults, study finds
Atlas of proteins reveals inner workings of cells Researchers discover how proteins behave inside cells using AI, which has the potential to guide drug design. Read more …Atlas of proteins reveals inner workings of cells